Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antirheumatic Agents | 2 | 2021 | 1373 | 0.760 |
Why?
|
MEDLARS | 1 | 2020 | 5 | 0.730 |
Why?
|
Rheumatology | 2 | 2021 | 615 | 0.610 |
Why?
|
World Health Organization | 3 | 2020 | 1322 | 0.570 |
Why?
|
Bibliometrics | 1 | 2020 | 352 | 0.540 |
Why?
|
Arthritis, Rheumatoid | 2 | 2021 | 3763 | 0.510 |
Why?
|
Rehabilitation Centers | 1 | 2016 | 246 | 0.460 |
Why?
|
Conflict of Interest | 1 | 2017 | 554 | 0.390 |
Why?
|
Glucocorticoids | 1 | 2021 | 2161 | 0.380 |
Why?
|
Drug Industry | 1 | 2017 | 788 | 0.350 |
Why?
|
Radiography | 1 | 2020 | 6965 | 0.330 |
Why?
|
Ultrasonography | 1 | 2020 | 5971 | 0.280 |
Why?
|
Disabled Persons | 1 | 2016 | 1226 | 0.260 |
Why?
|
Water | 1 | 2011 | 1411 | 0.240 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.240 |
Why?
|
Tuberous Sclerosis | 2 | 2024 | 1030 | 0.230 |
Why?
|
Caregivers | 1 | 2016 | 2238 | 0.220 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3462 | 0.210 |
Why?
|
Germ-Line Mutation | 2 | 2021 | 1858 | 0.210 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7391 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4016 | 0.200 |
Why?
|
Health Personnel | 1 | 2016 | 3335 | 0.200 |
Why?
|
Lung | 1 | 2020 | 10002 | 0.190 |
Why?
|
Ritanserin | 1 | 2021 | 9 | 0.190 |
Why?
|
Diacylglycerol Kinase | 1 | 2021 | 46 | 0.190 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 82 | 0.190 |
Why?
|
Pinocytosis | 1 | 2021 | 62 | 0.180 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2019 | 8 | 0.180 |
Why?
|
Trypanosomiasis, African | 1 | 2019 | 30 | 0.170 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2021 | 200 | 0.170 |
Why?
|
Antiprotozoal Agents | 1 | 2019 | 94 | 0.160 |
Why?
|
Lysosomes | 2 | 2021 | 924 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4591 | 0.160 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2021 | 201 | 0.160 |
Why?
|
Nitroimidazoles | 1 | 2019 | 117 | 0.160 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 318 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 698 | 0.150 |
Why?
|
Carcinoma, Lobular | 1 | 2021 | 481 | 0.140 |
Why?
|
Cadherins | 1 | 2021 | 903 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20568 | 0.140 |
Why?
|
Gift Giving | 1 | 2017 | 76 | 0.140 |
Why?
|
Lebanon | 1 | 2017 | 245 | 0.130 |
Why?
|
Smoking | 2 | 2022 | 9053 | 0.130 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 69 | 0.130 |
Why?
|
Remission Induction | 1 | 2021 | 2397 | 0.120 |
Why?
|
Kidney Neoplasms | 4 | 2024 | 4251 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 5314 | 0.110 |
Why?
|
Lung Neoplasms | 3 | 2022 | 13381 | 0.110 |
Why?
|
Public Opinion | 1 | 2017 | 484 | 0.110 |
Why?
|
Trust | 1 | 2017 | 530 | 0.100 |
Why?
|
Emergency Treatment | 1 | 2016 | 496 | 0.100 |
Why?
|
Biological Products | 1 | 2021 | 914 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1459 | 0.090 |
Why?
|
Consensus | 1 | 2021 | 3124 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 4001 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6312 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1998 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2021 | 64685 | 0.090 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 513 | 0.090 |
Why?
|
Specialties, Surgical | 1 | 2015 | 389 | 0.090 |
Why?
|
Middle East | 1 | 2011 | 231 | 0.090 |
Why?
|
Comprehension | 1 | 2015 | 621 | 0.090 |
Why?
|
Young Adult | 8 | 2021 | 59260 | 0.090 |
Why?
|
Asia | 1 | 2011 | 619 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 2 | 2021 | 3165 | 0.080 |
Why?
|
Societies, Medical | 1 | 2021 | 3905 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 10212 | 0.080 |
Why?
|
Publishing | 1 | 2015 | 833 | 0.070 |
Why?
|
Pharyngitis | 1 | 2009 | 220 | 0.070 |
Why?
|
Adolescent | 8 | 2021 | 88326 | 0.070 |
Why?
|
Patient Preference | 1 | 2015 | 927 | 0.070 |
Why?
|
Humans | 20 | 2022 | 761596 | 0.070 |
Why?
|
Australia | 1 | 2011 | 1250 | 0.070 |
Why?
|
Patient Participation | 1 | 2015 | 1445 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1175 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2084 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4652 | 0.060 |
Why?
|
Prevalence | 4 | 2021 | 15733 | 0.060 |
Why?
|
Switzerland | 2 | 2016 | 324 | 0.060 |
Why?
|
Adult | 11 | 2021 | 221210 | 0.060 |
Why?
|
Middle Aged | 10 | 2021 | 220921 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58984 | 0.050 |
Why?
|
Germany | 2 | 2016 | 875 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15843 | 0.050 |
Why?
|
Mutation | 3 | 2022 | 30053 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1866 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6938 | 0.050 |
Why?
|
Angiolipoma | 1 | 2021 | 11 | 0.050 |
Why?
|
Genealogy and Heraldry | 1 | 2021 | 29 | 0.050 |
Why?
|
Phosphatidic Acids | 1 | 2021 | 49 | 0.050 |
Why?
|
Female | 12 | 2021 | 392705 | 0.050 |
Why?
|
Phosphoserine | 1 | 2021 | 203 | 0.050 |
Why?
|
Nifurtimox | 1 | 2019 | 14 | 0.040 |
Why?
|
Eflornithine | 1 | 2019 | 31 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2024 | 0.040 |
Why?
|
Canada | 2 | 2016 | 2122 | 0.040 |
Why?
|
Internationality | 2 | 2015 | 1001 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2319 | 0.040 |
Why?
|
Chloroquine | 1 | 2021 | 274 | 0.040 |
Why?
|
Penetrance | 1 | 2021 | 383 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2022 | 4514 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
Male | 9 | 2021 | 360846 | 0.040 |
Why?
|
Decision Making | 2 | 2010 | 3929 | 0.040 |
Why?
|
United States | 2 | 2021 | 72340 | 0.040 |
Why?
|
Aged | 7 | 2021 | 169310 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 786 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1827 | 0.030 |
Why?
|
Drug Synergism | 1 | 2021 | 1757 | 0.030 |
Why?
|
Sirolimus | 1 | 2024 | 1533 | 0.030 |
Why?
|
Tumor Burden | 1 | 2022 | 1892 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2626 | 0.030 |
Why?
|
Hospitalization | 1 | 2016 | 10721 | 0.030 |
Why?
|
Protein Transport | 1 | 2021 | 1967 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2021 | 10451 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3094 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3614 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21019 | 0.030 |
Why?
|
Social Values | 1 | 2015 | 225 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1745 | 0.030 |
Why?
|
Utilization Review | 1 | 2015 | 382 | 0.030 |
Why?
|
Down-Regulation | 1 | 2021 | 2919 | 0.030 |
Why?
|
Autophagy | 1 | 2021 | 1327 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2022 | 2425 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2021 | 2910 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22173 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4281 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2735 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2021 | 2805 | 0.020 |
Why?
|
Risk | 2 | 2015 | 9610 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7406 | 0.020 |
Why?
|
Mice | 3 | 2024 | 81539 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4740 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4142 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8321 | 0.020 |
Why?
|
Hypertension | 1 | 2010 | 8540 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17904 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2358 | 0.020 |
Why?
|
Norway | 1 | 2010 | 499 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14417 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42232 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7593 | 0.020 |
Why?
|
Medicine | 1 | 2015 | 942 | 0.020 |
Why?
|
Animals | 3 | 2024 | 168475 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2010 | 15502 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11904 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4244 | 0.010 |
Why?
|
Child | 2 | 2021 | 80158 | 0.010 |
Why?
|
Attitude to Health | 1 | 2010 | 2025 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13255 | 0.010 |
Why?
|
Pain Measurement | 1 | 2010 | 3551 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26202 | 0.010 |
Why?
|
Internet | 1 | 2010 | 3093 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36193 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 13367 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29890 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41495 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 74213 | 0.000 |
Why?
|
Risk Assessment | 1 | 2009 | 23996 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2016 | 80647 | 0.000 |
Why?
|
Concepts
(162)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_